These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29674498)

  • 1. Microenvironmental M1 tumor-associated macrophage polarization influences cancer-related anemia in advanced ovarian cancer: key role of interleukin-6.
    Madeddu C; Gramignano G; Kotsonis P; Coghe F; Atzeni V; Scartozzi M; Macciò A
    Haematologica; 2018 Sep; 103(9):e388-e391. PubMed ID: 29674498
    [No Abstract]   [Full Text] [Related]  

  • 2. MiR-217 Inhibits M2-Like Macrophage Polarization by Suppressing Secretion of Interleukin-6 in Ovarian Cancer.
    Jiang B; Zhu SJ; Xiao SS; Xue M
    Inflammation; 2019 Oct; 42(5):1517-1529. PubMed ID: 31049770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered monocyte differentiation and macrophage polarization patterns in patients with breast cancer.
    Hung CH; Chen FM; Lin YC; Tsai ML; Wang SL; Chen YC; Chen YT; Hou MF
    BMC Cancer; 2018 Apr; 18(1):366. PubMed ID: 29614988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astragaloside IV antagonizes M2 phenotype macrophage polarization-evoked ovarian cancer cell malignant progression by suppressing the HMGB1-TLR4 axis.
    Wang X; Gao S; Song L; Liu M; Sun Z; Liu J
    Mol Immunol; 2021 Feb; 130():113-121. PubMed ID: 33308900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of Polarization of Resident Macrophages and Their Effect on the Tumor Microenvironment.
    Pateras IS; Cooks T
    Methods Mol Biol; 2019; 1928():101-112. PubMed ID: 30725453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse macrophages polarization in tumor microenvironment.
    Rhee I
    Arch Pharm Res; 2016 Nov; 39(11):1588-1596. PubMed ID: 27562774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage Polarization States in the Tumor Microenvironment.
    Boutilier AJ; Elsawa SF
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of hypoxia inducible factors on the immune microenvironment in ovarian cancer.
    Duechler M; Peczek L; Szubert M; Suzin J
    Anticancer Res; 2014 Jun; 34(6):2811-9. PubMed ID: 24922644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DFMO and 5-Azacytidine Increase M1 Macrophages in the Tumor Microenvironment of Murine Ovarian Cancer.
    Travers M; Brown SM; Dunworth M; Holbert CE; Wiehagen KR; Bachman KE; Foley JR; Stone ML; Baylin SB; Casero RA; Zahnow CA
    Cancer Res; 2019 Jul; 79(13):3445-3454. PubMed ID: 31088836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Head and neck squamous cell carcinoma cell lines have an immunomodulatory effect on macrophages independent of hypoxia and toll-like receptor 9.
    Ishizu T; Eichin D; Padzik A; Tuominen S; Grénman R; Salmi M; Grönroos TJ; Tuomela JM
    BMC Cancer; 2021 Sep; 21(1):990. PubMed ID: 34479492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes promote pre-metastatic niche formation in ovarian cancer.
    Feng W; Dean DC; Hornicek FJ; Shi H; Duan Z
    Mol Cancer; 2019 Aug; 18(1):124. PubMed ID: 31409361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients.
    Zhang M; He Y; Sun X; Li Q; Wang W; Zhao A; Di W
    J Ovarian Res; 2014 Feb; 7():19. PubMed ID: 24507759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chamaejasmenin B, an Inhibitor for Metastatic Outgrowth, Reversed M2-Dominant Macrophage Polarization in Breast Tumor Microenvironment.
    Li Q; Sun L; Liu L; Ran Q; Du X; Yang Q; Wang Y; Li Y; Chen Y; Weng X; Cai W; Zhu X
    Front Immunol; 2021; 12():774230. PubMed ID: 35027915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-inflammatory M1 macrophage enhances metastatic potential of ovarian cancer cells through NF-κB activation.
    Cho U; Kim B; Kim S; Han Y; Song YS
    Mol Carcinog; 2018 Feb; 57(2):235-242. PubMed ID: 29024042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcriptional signature of human ovarian carcinoma macrophages is associated with extracellular matrix reorganization.
    Finkernagel F; Reinartz S; Lieber S; Adhikary T; Wortmann A; Hoffmann N; Bieringer T; Nist A; Stiewe T; Jansen JM; Wagner U; Müller-Brüsselbach S; Müller R
    Oncotarget; 2016 Nov; 7(46):75339-75352. PubMed ID: 27659538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer.
    Ojalvo LS; Thompson ED; Wang TL; Meeker AK; Shih IM; Fader AN; Cimino-Mathews A; Emens LA
    Hum Pathol; 2018 Apr; 74():135-147. PubMed ID: 29288043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse.
    Reinartz S; Schumann T; Finkernagel F; Wortmann A; Jansen JM; Meissner W; Krause M; Schwörer AM; Wagner U; Müller-Brüsselbach S; Müller R
    Int J Cancer; 2014 Jan; 134(1):32-42. PubMed ID: 23784932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of M1-polarized tumor-associated macrophages in the prognosis of advanced ovarian cancer patients.
    Macciò A; Gramignano G; Cherchi MC; Tanca L; Melis L; Madeddu C
    Sci Rep; 2020 Apr; 10(1):6096. PubMed ID: 32269279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal dysbiosis promotes epithelial-mesenchymal transition by activating tumor-associated macrophages in ovarian cancer.
    Xu S; Liu Z; Lv M; Chen Y; Liu Y
    Pathog Dis; 2019 Mar; 77(2):. PubMed ID: 30916767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the polarization of tumor-associated macrophages and modulating mir-155 expression might be a new approach to treat diffuse large B-cell lymphoma of the elderly.
    Poles WA; Nishi EE; de Oliveira MB; Eugênio AIP; de Andrade TA; Campos AHFM; de Campos RR; Vassallo J; Alves AC; Scapulatempo Neto C; Paes RAP; Landman G; Zerbini MCN; Colleoni GWB
    Cancer Immunol Immunother; 2019 Feb; 68(2):269-282. PubMed ID: 30430204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.